(COCO) Vita Coco - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US92846Q1076
COCO EPS (Earnings per Share)
COCO Revenue
COCO: Coconut Water, Coconut Oil, Coconut Juice, Coconut Milk, Packaged Water, Fitness Drinks, Private Label Products
The Vita Coco Company, Inc. is a leading player in the coconut water market, operating under the Vita Coco brand name across multiple regions including the United States, Canada, Europe, the Middle East, Africa, and the Asia Pacific. Beyond coconut water, the company has diversified its product portfolio to include coconut oil, coconut juice, coconut milk, and packaged water under the Ever & Ever brand. Additionally, it offers PWR LIFT, a protein-infused fitness drink catering to the fitness and wellness segment. The company also engages in private label manufacturing for retailers, expanding its reach across various distribution channels including club stores, food, drug, mass market, convenience stores, e-commerce, and foodservice.
With a history dating back to its incorporation in 2004 as All Market Inc., the company rebranded to The Vita Coco Company, Inc. in September 2021, marking a significant milestone in its evolution. Headquartered in New York, New York, Vita Coco has established itself as a significant entity in the beverage industry, particularly within the soft drinks and non-alcoholic beverages segment.
Analyzing the companys
Forecasting the future performance of COCO based on the available data, the stock is likely to experience a positive trajectory. The relatively stable SMA50 and SMA200 values suggest a strong support level around $33, and with the current price being slightly above this, theres potential for upward movement. The companys diversified product portfolio and its presence in multiple geographies provide a solid foundation for growth. Additionally, the beverage industrys trend towards healthier and natural products aligns with Vita Cocos offerings, potentially driving demand. Thus, a forecast of reaching towards the 52-week high of $40.30 within the next 6-12 months is plausible, contingent upon continued strong financial performance and favorable market conditions.
Additional Sources for COCO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
COCO Stock Overview
Market Cap in USD | 1,943m |
Sector | Consumer Defensive |
Industry | Beverages - Non-Alcoholic |
GiC Sub-Industry | Soft Drinks & Non-alcoholic Beverages |
IPO / Inception | 2021-10-21 |
COCO Stock Ratings
Growth Rating | 64.4 |
Fundamental | 63.0 |
Dividend Rating | 0.0 |
Rel. Strength | -1.89 |
Analysts | 3.9 of 5 |
Fair Price Momentum | 33.14 USD |
Fair Price DCF | 6.29 USD |
COCO Dividends
Currently no dividends paidCOCO Growth Ratios
Growth Correlation 3m | 39.1% |
Growth Correlation 12m | 62.1% |
Growth Correlation 5y | 89.6% |
CAGR 5y | 27.80% |
CAGR/Max DD 5y | 0.49 |
Sharpe Ratio 12m | 0.97 |
Alpha | -3.32 |
Beta | 1.134 |
Volatility | 49.92% |
Current Volume | 352.2k |
Average Volume 20d | 444k |
As of June 15, 2025, the stock is trading at USD 33.06 with a total of 352,215 shares traded.
Over the past week, the price has changed by -3.47%, over one month by -0.27%, over three months by -4.28% and over the past year by +9.11%.
Yes, based on ValueRay´s Fundamental Analyses, Vita Coco (NASDAQ:COCO) is currently (June 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 63.04 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of COCO is around 33.14 USD . This means that COCO is currently overvalued and has a potential downside of 0.24%.
Vita Coco has received a consensus analysts rating of 3.90. Therefor, it is recommend to buy COCO.
- Strong Buy: 4
- Buy: 1
- Hold: 5
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, COCO Vita Coco will be worth about 38.2 in June 2026. The stock is currently trading at 33.06. This means that the stock has a potential upside of +15.61%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 38.7 | 17% |
Analysts Target Price | 38.2 | 15.6% |
ValueRay Target Price | 38.2 | 15.6% |